Split History
8% "No Withdrawal" Portfolio »    IBB Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
iShares Nasdaq Biotechnology Index Fund is an open-end management investment company. The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. As of Mar 31 2015, the Fund's total assets were $9,494,443,846 and the Fund's investment portfolio was valued at $9,486,288,900. According to our IBB split history records, iShares Trust - iShares Nasdaq Biotechnology ETF has had 1 split.
IBB split history picture
iShares Trust - iShares Nasdaq Biotechnology ETF (IBB) has 1 split in our IBB split history database. The split for IBB took place on December 01, 2017. This was a 3 for 1 split, meaning for each share of IBB owned pre-split, the shareholder now owned 3 shares. For example, a 1000 share position pre-split, became a 3000 share position following the split.

When a company such as iShares Trust - iShares Nasdaq Biotechnology ETF splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.

Looking at the IBB split history from start to finish, an original position size of 1000 shares would have turned into 3000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into iShares Trust - iShares Nasdaq Biotechnology ETF shares, starting with a $10,000 purchase of IBB, presented on a split-history-adjusted basis factoring in the complete IBB split history. IBB split adjusted history picture

Growth of $10,000.00
With Dividends Reinvested

Start date: 09/20/2010
End date: 09/18/2020
Start price/share: $28.94
End price/share: $136.32
Starting shares: 345.54
Ending shares: 353.68
Dividends reinvested/share: $1.66
Total return: 382.14%
Average Annual Total Return: 17.03%
Starting investment: $10,000.00
Ending investment: $48,212.45
Years: 10.00
 
Growth of $10,000.00
Without Dividends Reinvested

Start date: 09/20/2010
End date: 09/18/2020
Start price/share: $28.94
End price/share: $136.32
Dividends collected/share: $1.66
Total return: 376.79%
Average Annual Total Return: 16.90%
Starting investment: $10,000.00
Ending investment: $47,679.41
Years: 10.00
Date Ratio
12/01/20173 for 1
IBB is categorized under the Financials sector; below are some other companies in the same sector that also have a history of stock splits:

IBCP Split History
IBKC Split History
IBME Split History
IBMF Split History
IBN Split History
IBOC Split History
ICE Split History
ICF Split History
ICN Split History
IDX Split History

Also explore: IBB shares outstanding history

Rush Enterprises, Inc. (RUSHB)
Rush Enterprises, Inc. (RUSHA)
Silver Bull Resources, Inc. (SVB.CA)
Eagle Bulk Shipping Inc. (EGLE)
Biocept, Inc. (BIOC)
China Ceramics Co., Ltd. (CCCL)
Sunesis Pharmaceuticals, Inc. (SNSS)
Urban Tea Inc. (MYT)
Intrepid Potash Inc. (IPI)
Tesla, Inc. (TSLA)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

IBB Split History | www.SplitHistory.com | Copyright © 2013 - 2020, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.